Chronic pyelonephritis occurs in patients at risk for...
Artículos Científicos en Ingles
Artículos Científicos RSS AJKD
AJKD Atlas of Renal Pathology: Chronic Pyelonephritis | CKD and Cardiovascular Events: Unraveling the Disparities Among MinoritiesChronic kidney disease (CKD) is a national public health... | Spironolactone in Dialysis: What’s Old Is New AgainIndividuals receiving maintenance dialysis therapy have... |
Quiz Page October 2016A 55-year-old smoker presented with 3 weeks of dyspnea... | Distinguishing the Signals From the Noise: Can Epidemiologic Studies Inform Our Understanding of Glomerular Disease?Epidemiology fundamentally aims to elucidate the... | Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysisTo simultaneously evaluate the relative efficacy of... |
AJKD Atlas of Renal Pathology: Alport SyndromePatients with Alport syndrome present with hematuria in... | Preeclampsia and ESRD: The Role of Shared Risk FactorsSeveral registry-based studies, using diagnostic codes,... |
Artículos Científicos RSS JASN
Current and Emerging Therapies for Lupus NephritisThe introduction of corticosteroids and later,... | Prorenin Receptor, a Necessary Component in Urine Concentration MechanismEste artículo no posee resumen | Validation of a Three-Dimensional Method for Counting and Sizing Podocytes in Whole GlomeruliPodocyte depletion is sufficient for the development of... |
EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water ReabsorptionNephrogenic diabetes insipidus (NDI) is caused by... | YAP/TAZ Are Mechanoregulators of TGF-{beta}-Smad Signaling and Renal FibrogenesisLike many organs, the kidney stiffens after injury, a... | Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment ReformErythropoiesis-stimulating agents (ESAs) are commonly... |
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRDThe association between proton pump inhibitors (PPI) use... |


